Home > Healthcare IT > Pain Management Therapeutics Market Growth, Types Forecast to 2026 | StraitsResearch
Straits Research

Pain Management Therapeutics Market

Pain Management Therapeutics Market: Information By Drug Class, Indication, Distribution Channel and Regional Outlook — Forecast Till 2026

Table of Content Download Sample

Market Snapshot

market snapshot
Base Year:
2017
Study Period:
2016-2026
CAGR:
4.3 %
Fastest Growing Market:
Europe
Largest Market:
North America

Global Statistics Representing Pain Management Therapeutics Market Scenario

Pain management therapy involves various treatments such as acupuncture, chiropractic treatment, yoga, hypnosis, biofeedbackaromatherapy, relaxation, herbal remedies, massage, therapeutic touch, medication and many others.

According to the Institute of Neurological Disorder and Stroke, approximately 80% of adults suffers from back pain due to various factors such as job-related disability, repeated heavy lifting, and osteoporosis. Increasing prevalence of cervical spinal stenosis among women is likely to spur the prevalence of back pain which in turn is expected to drive the market.

In postmenopausal women body produces less estrogen which leads to decrease in calcium absorption. Thereby, increasing breakdown of bones and other bone related diseases further supporting the market growth.

The global pain management therapeutics market accounted for over USD 58,000 million in 2017 and is expected to grow at a CAGR of 4.3% during the forecast period, 2019–2026.

Global-Pain-Management-Therapeutics-Market

To learn more about key trends >> Download Sample Report

Intended Audience

  • Pharmaceutical Industry
  • Hospitals and Clinics
  • Biotechnological Institutes
  • Medical Research Laboratories
  • Potential Investors
  • Research and Development Institutes

Segmental Insight

Global pain management therapeutics is segmented into drug class, indication, distribution channel, and region.

On the basis of drug class, the market is segmented into anesthetics, NSAIDS, anticonvulsants, antidepressants, anti-migraine agents, non-narcotic analgesics, and opioids. Opioids segment is further segmented into tramadol, oxycodone, hydrocodone, and other. The opioids and NSAIDS segments holds the largest share on account of easy availability of NSAIDs on over the counter drugs such as ibuprofen, aspirin, and diclofenac.

On the basis of indication, the market is segmented into neuropathic pain, arthritic pain, cancer pain, post-operative pain, chronic back pain, fibromyalgia, and migraine. Increasing prevalence of osteonecrosis and back pain in the developed and developing region is expected to support the market growth.

Based on distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. Hospitals pharmacy is leading segment in the distribution channel segment owing to the increasing number of hospitals across the globe with technologically advanced services.

Regional Insights

Geographically, the global pain management therapeutics market is segmented into North America, Europe, Asia Pacific, and Latin America and the Middle East & Africa (LAMEA).

North-America-Pain-Management-Therapeutics-Market

To understand geography trends >> Download Sample Report

North America is expected to hold the major share of the market due to huge presence of baby boomer population suffering from back pain. For instance, according to the Population Reference Bureau, in 2016, over 46 million people in America are of the age above 65.  Furthermore, chronic diseases such as cancer has major impact on North America. For instance, according to the National Cancer Institute, around 1.7 million new cases of cancer were diagnosed in the U.S. Thus, increasing prevalence of cancer is likely to fuel the market growth over the forecast period 2019–2026..

Europe has several opportunities in pain management therapeutics market on account of growing prevalence of osteoporosis due to aging, calcium deficiency, increasing alcohol consumption. According to the International Osteoporosis Foundation (IOF), in 2015, approximately 20 million people above the age of 50 suffered from osteoporosis.

Asia Pacific is expected to be the fastest growing market for pain management therapeutics. Increasing prevalence of various diseases such as depression, migraine, and spondylitis is supporting the market growth.  For instance, according to the World Health Organization (WHO), 4.5 % of Indian population suffered from depression in 2016. Increasing prevalence of depression due unhealthy diet and modernization is anticipated to positively influence the market growth.

Latin America offers slow growth prospects on account of osteoporosis which is more common in Latin American people. Increasing number of incidences of osteoporosis in Mexico, Brazil, Argentina, Bolivia, Puerto Rico and Colombia countries is expected to boost the market growth in the coming years. In the Middle East and Africa growing population and rise in per capita income is driving the market.

Key Players

Some of the major players in the pain management therapeutics market are Novartis AG, Eli Lilly & Company, Abbott Laboratories, Endo Health Solutions, Inc., Purdue Pharma L.P., Pfizer, Inc., F. Hoffmann La Roche Ltd., Merck & Co. Inc., Johnson & Johnson, and GlaxoSmithKline Plc.

Report Scope

Report Metric Details
Market Size USD 58,000 million in 2017
CAGR CAGR 4.3%
Historical Data 2015-2016
Base Year 2017
Forecast Period 2018-2026
Forecast Units Value (USD Million)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Segments Covered by Drug Class, Indication, Distribution Channel
Geographies Covered North America, Europe, Asia-Pacific, LAME and Rest of the World
Key Companies Profiled/Vendors Novartis AG, Eli Lilly & Company, Abbott Laboratories, Endo Health Solutions, Inc., Purdue Pharma L.P., Pfizer, Inc., F. Hoffmann La Roche Ltd., Merck & Co. Inc., Johnson & Johnson, and GlaxoSmithKline Plc.,
Key Market Opportunities Increasing Prevalence Of The Healthcare It Industry Enhances The Expansion Of The Pain Management Therapeutics Market Share

Pain Management Therapeutics Market Segmentation

By Drug Class

  • NSAIDS
  • Anticonvulsants
  • Antidepressants
  • Anti-migraine agents
  • Non-narcotic analgesics
  • Opioids
    • Tramadol
    • Oxycodone
    • Hydrocodone
    • Others

By Indication

  • Neuropathic Pain
  • Arthritic Pain
  • Cancer pain
  • Post-operative Pain
  • Chronic Back Pain
  • Fibromyalgia
  • A migraine    

By Distribution Channel

  • Hospitals Pharmacy 
  • Retail Pharmacy
  • Online Pharmacy 

By Regions

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Why Buy This Report?

  • Historical inferences, findings & analysis of the market from 2016 to 2018
  • Projections and performance forecast analysis for the future from 2019 to 2026
  • Production and consumption point of view (POV) analysis
  • Market drivers, restraint and opportunity analysis, to define market dynamics covering industry, regulatory, innovation, technological & pricing trends
  • Comprehensive competitive landscape mapping with recent development covering market leadership, competency, sustainability, and prospects
Price Starts From
USD4250

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report
Want to learn more about recent trends and data ?
They Already Trust Us :
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Johnson & Johnson
Need Assistance?
+1 646 480 7505 (U.S.)
+44 208 068 9665 (U.K.)
Looking For Custom Report ?

Report Benefits

  • Develop business strategies by understanding the trends shaping and driving the Market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track sales in the global and country-specific Market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Check Our License Options :
Report Snapshot

As featured on :

clients
Trusted by Fortune 500
Over 30000+ subscribers